Company Filing History:
Years Active: 2009
Title: Birgit Øvstebø Engesæter: Innovator in Photochemical Internalization
Introduction
Birgit Øvstebø Engesæter is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of molecular delivery systems, particularly in the context of cancer treatment and gene therapy. His innovative approach has the potential to revolutionize how therapeutic molecules are introduced into cells.
Latest Patents
Engesæter holds a patent for a method titled "Photochemical internalization for virus-mediated molecule delivery into the cytosol." This patent describes a technique for introducing a molecule into the cytosol of a cell. The process involves contacting the cell with a photosensitizing agent, irradiating the cell with light to activate the agent, and subsequently introducing the desired molecule. This method is particularly relevant for applications in cancer treatment, gene therapy, and vaccination. He has 1 patent to his name.
Career Highlights
Engesæter is associated with Pci Biotech AS, a company focused on developing innovative therapies using photochemical internalization technology. His work at the company has positioned him as a key player in advancing therapeutic strategies that leverage light-activated processes for enhanced drug delivery.
Collaborations
Engesæter has collaborated with notable colleagues, including Anders Høgset and Kristian Berg. Their combined expertise has contributed to the development of cutting-edge solutions in the field of molecular delivery.
Conclusion
Birgit Øvstebø Engesæter's work exemplifies the intersection of innovation and practical application in medical science. His contributions to photochemical internalization are paving the way for new therapeutic approaches that could significantly impact patient care.